Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept Monotherapy in Kidney Transplant Patients
NCT04786067Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2021
- Primary completion
- Jul 2025
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of belatacept in kidney transplant rejection, sponsored by UT Southwestern Medical Center. Started Jul 2021; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT04786067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04786067.